Essentiale forte N

Medicinal product

(Invented) name

Essentiale forte N

Active substance (s)

Sojų fosfolipidai

Strength

300 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A05BA10, phospholipids

Marketing authorisation holder

Opella Healthcare France SAS, Prancūzija

Date of authorisation

2001-05-16

Date of renewal

2012-06-15

Documents

2976 Pakuotės lapelis 300mg 2024 03 11.docx

2976 Essentiale forte N 300 II PL 2024 03 11.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Sojų fosfolipidai	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
7519	12463	1012463	lizdinė plokštelė	N30		Nereceptinis	LT/1/01/2976/001	Tiekiama	-	-	No	-	-	Download
98614	84718	1084718	lizdinė plokštelė	N100		Nereceptinis	LT/1/01/2976/005	Netiekiama	2025-02-19	-	No	-	-	Download
111796	97911	1097911	lizdinė plokštelė	N90		Nereceptinis	LT/1/01/2976/006	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2012-06-15	Perregistruotas
2001-05-16	Registruotas